Bio Essence Corp. Changes Certifying Accountant
Ticker: BIOE · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1723059
| Field | Detail |
|---|---|
| Company | Bio Essence CORP (BIOE) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, sec-filing
TL;DR
Bio Essence Corp. swapped its auditor, filing an 8-K on Aug 5, 2024.
AI Summary
Bio Essence Corp. has filed an 8-K report on August 5, 2024, to disclose a change in its certifying accountant. The company, incorporated in California with its principal executive offices in Irvine, CA, is reporting this change as required by SEC regulations.
Why It Matters
A change in a company's auditor can signal potential concerns about financial reporting or internal controls, which is important for investors to monitor.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a change in auditor and does not inherently indicate financial distress or significant operational changes.
Key Numbers
- 949-706-9966 — Issuer Telephone Number (Contact information for Bio Essence Corp.)
Key Players & Entities
- Bio Essence Corp. (company) — Registrant
- August 5, 2024 (date) — Filing Date
- California (jurisdiction) — State of Incorporation
- Irvine, CA (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a change in Bio Essence Corp.'s certifying accountant.
When was this 8-K report filed?
This 8-K report was filed on August 5, 2024.
Where are Bio Essence Corp.'s principal executive offices located?
Bio Essence Corp.'s principal executive offices are located at 12 Chrysler, Unit B, Irvine, CA 92618.
In which state was Bio Essence Corp. incorporated?
Bio Essence Corp. was incorporated in California.
What is the SIC code for Bio Essence Corp.?
The Standard Industrial Classification (SIC) code for Bio Essence Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 569 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-08-05 17:14:07
Filing Documents
- ea0210631-8k_bioessence.htm (8-K) — 24KB
- 0001213900-24-065237.txt ( ) — 190KB
- bioe-20240805.xsd (EX-101.SCH) — 3KB
- bioe-20240805_lab.xml (EX-101.LAB) — 33KB
- bioe-20240805_pre.xml (EX-101.PRE) — 22KB
- ea0210631-8k_bioessence_htm.xml (XML) — 3KB
01 Changes om Registrant's Certifying Accountant
Item 4.01 Changes om Registrant's Certifying Accountant On August 1, 2024, Bio Essence Corp., a California corporation (the "Company") dismissed its prior independent accountant, Keith K. Zhen, CPA. The prior financial statements for the past two years do not contain any adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles. The decision to change auditors and dismiss Keith K. Zhen, CPA, was reviewed and recommended by the Board of Directors, but not formally approved. During the last two fiscal years, the Company did not have any disagreements with the former accountant on any matter of accounting principles or practices, financial statement disclosure, or auditing score or procedure. No further disclosures are required under Section 304(a)(1)(v) of Regulation S-K. A copy of this Current Report on Form 8-K has been furnished to Keith K. Zhen, CPA, and the Company has requested that Keith K. Zhen, CPA provide a letter addressed to the U.S. Securities and Exchange Commission ("Commission") providing the information required by Section 304(c) of Regulation S-K, and upon receipt of the same, the Company shall it with the Commission. Also on August 1, 2024, the Company retained Simon & Edward, LLP ("S&E") to serve as the Company's principal accountant to audit the Company's financial 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO ESSENCE CORP. /s/ Yin Yan By: Yin Yan Its: Chief Executive Officer Dated: August 5, 2024 2